Ginsenoside Rh4 effectively inhibits PD-L1 expression by regulating histone deacetylase 2 (HDAC2)-mediated JAK/STAT signaling pathways in breast cancer cells, while demonstrating high binding affinity with HDAC2 through molecular docking analysis [185]. Here, HDAC2 is linked to breast cancer.